Portions of this exhibit marked [*] are requested to be treated confidentially. DEVELOPMENT AND LICENSE AGREEMENT By and Between DEBIOVISION INC. and SALIX PHARMACEUTICALS, INC. September 5, 2006Development and License Agreement • November 9th, 2006 • Salix Pharmaceuticals LTD • Pharmaceutical preparations • New York
This Development and License Agreement, dated the 5th day of September, 2006 (the “Effective Date”), is by and between SALIX PHARMACEUTICALS, INC., a corporation organized and existing under the laws of California, USA and having its place of business at 1700 Perimeter Park Drive, Morrisville, NC 27560-8404 U.S.A. (“Salix”), and DEBIOVISION INC., a company organized and existing under the laws of Quebec and having its place of business at 666 Sherbrooke Street West, Suite 1400, Montreal, Quebec H3A 1E7, Canada (“Debiovision”).
